Company Name:Galapagos NV
CEO: Onno van de Stolpe

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions.


Key numbers

Market Capitalization:11384010750
Shares Outstanding: 61953800
Float: 61855851.0422
Next Earning Date:2020-02-20
TTm EPS: 5.2935
TTm Dividend Rate:
200 days moving average:138.05
50 days moving average: 165.34
One day percent Change: 1.18



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,